US Stock MarketDetailed Quotes
ZOM Zomedica
- 0.1280
- -0.0004-0.31%
Close Nov 29 13:00 ET
- 0.1286
- +0.0006+0.43%
Post 17:01 ET
125.43MMarket Cap-1969P/E (TTM)
0.1300High0.1280Low2.87MVolume0.1299Open0.1284Pre Close369.83KTurnover0.30%Turnover RatioLossP/E (Static)979.95MShares0.228552wk High0.62P/B123.09MFloat Cap0.117052wk Low--Dividend TTM961.66MShs Float2.9800Historical High--Div YieldTTM1.56%Amplitude0.0628Historical Low0.1280Avg Price1Lot Size
Zomedica Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.24%7M | 1.84%6.13M | 14.23%6.26M | 33.05%25.19M | 19.17%7.34M | 32.89%6.35M | 41.78%6.02M | 46.15%5.48M | 358.02%18.93M | 50.87%6.16M |
| Operating revenue | 10.24%7M | 1.84%6.13M | 14.23%6.26M | 33.05%25.19M | 19.17%7.34M | 32.89%6.35M | 41.78%6.02M | 46.15%5.48M | 358.02%18.93M | 50.87%6.16M |
| Cost of revenue | -2.42%1.94M | -10.29%1.77M | 30.24%2.15M | 44.05%7.87M | 16.34%2.26M | 56.92%1.99M | 59.03%1.97M | 62.91%1.65M | 406.21%5.46M | 90.78%1.95M |
| Gross profit | 16.00%5.06M | 7.76%4.36M | 7.35%4.12M | 28.59%17.32M | 20.47%5.07M | 24.24%4.36M | 34.66%4.05M | 39.96%3.84M | 341.00%13.47M | 37.57%4.21M |
| Operating expense | 21.24%12.5M | 24.24%13.41M | 27.81%14.5M | 38.20%48.91M | 76.12%16.46M | 2.05%10.31M | 21.43%10.79M | 60.86%11.35M | 44.88%35.39M | 5.90%9.35M |
| Selling and administrative expenses | 12.83%10.66M | 19.82%11.9M | 22.08%12.73M | 31.55%43.17M | 54.41%13.36M | 6.24%9.44M | 15.92%9.93M | 55.59%10.43M | 44.20%32.81M | 6.04%8.65M |
| -Selling and marketing expense | 16.89%3.89M | 27.33%3.92M | 20.23%4.11M | 43.10%14.14M | 26.39%4.31M | -10.90%3.33M | --3.08M | --3.42M | --9.88M | --3.41M |
| -General and administrative expense | 10.63%6.77M | 16.44%7.98M | 22.99%8.63M | 26.58%29.03M | 72.65%9.05M | 18.67%6.12M | --6.85M | --7.01M | --22.93M | --5.24M |
| Research and development costs | 112.80%1.85M | 75.32%1.51M | 92.92%1.77M | 122.81%5.74M | 347.19%3.1M | -28.64%867K | 169.28%859K | 161.54%918K | 54.09%2.58M | 4.21%693K |
| Operating profit | -25.08%-7.44M | -34.13%-9.04M | -38.26%-10.39M | -44.10%-31.59M | -121.75%-11.39M | 9.77%-5.95M | -14.66%-6.74M | -74.13%-7.51M | -2.57%-21.92M | 10.91%-5.14M |
| Net non-operating interest income expense | -28.84%977K | -25.75%1.04M | -19.75%1.09M | 95.67%5.28M | -11.89%1.15M | 35.67%1.37M | 404.69%1.4M | 1,172.90%1.36M | 669.23%2.7M | 1,365.17%1.3M |
| Non-operating interest income | -32.01%977K | -28.90%1.04M | -22.59%1.09M | 102.07%5.46M | -11.95%1.15M | 42.00%1.44M | 427.08%1.46M | 1,219.63%1.41M | 656.58%2.7M | 1,273.68%1.31M |
| Non-operating interest expense | --0 | --0 | --0 | 17,400.00%175K | --0 | --64K | --62K | --50K | -83.33%1K | --1K |
| Other net income (expense) | -112.06%-261K | -89,372.22%-16.07M | -22.22%-33K | -5,944.94%-9.55M | -44,926.92%-11.71M | 3,105.56%2.16M | 134.62%18K | -237.50%-27K | -151.63%-158K | -150.00%-26K |
| Gain on sale of security | 64.44%-16K | -370.59%-46K | -396.15%-129K | 118.42%28K | 382.76%82K | 32.84%-45K | 132.69%17K | -271.43%-26K | -406.67%-152K | -20.83%-29K |
| Special income (charges) | -1,057.14%-134K | -1,607,600.00%-16.08M | --12K | -1,166,000.00%-11.66M | -583,800.00%-11.67M | --14K | 200.00%1K | --0 | -99.65%1K | -99.64%2K |
| -Write off | --0 | --16.02M | ---- | --11.68M | --11.68M | --0 | --0 | ---- | --0 | ---- |
| -Gain on sale of property,plant,equipment | -1,057.14%-134K | -5,200.00%-51K | --12K | 2,300.00%24K | 350.00%9K | --14K | 200.00%1K | --0 | 100.40%1K | -90.48%2K |
| Other non- operating income (expenses) | -105.06%-111K | --52K | 8,500.00%84K | 29,814.29%2.08M | -11,600.00%-115K | 44,000.00%2.2M | ---- | 0.00%-1K | -113.46%-7K | 100.21%1K |
| Income before tax | -178.89%-6.72M | -352.01%-24.07M | -50.98%-9.33M | -85.03%-35.86M | -468.87%-21.95M | 57.34%-2.41M | 5.82%-5.33M | -46.55%-6.18M | 6.45%-19.38M | 31.40%-3.86M |
| Income tax | 98.59%-27K | -85.71%-143K | -179.81%-166K | 43.74%-1.33M | 143.76%459K | -192.24%-1.92M | 79.84%-77K | 174.82%208K | -1.41%-2.37M | 55.04%-1.05M |
| Net income | -1,263.95%-6.7M | -355.92%-23.93M | -43.46%-9.16M | -102.93%-34.53M | -697.65%-22.41M | 90.17%-491K | 0.46%-5.25M | -62.18%-6.39M | 7.45%-17.02M | 14.65%-2.81M |
| Net income continuous Operations | -1,263.95%-6.7M | -355.92%-23.93M | -43.46%-9.16M | -102.93%-34.53M | -697.65%-22.41M | 90.17%-491K | 0.46%-5.25M | -62.18%-6.39M | 7.45%-17.02M | 14.65%-2.81M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -1,263.95%-6.7M | -355.92%-23.93M | -43.46%-9.16M | -102.93%-34.53M | -697.65%-22.41M | 90.17%-491K | 0.46%-5.25M | -62.18%-6.39M | 7.45%-17.02M | 14.65%-2.81M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -1,263.95%-6.7M | -355.92%-23.93M | -43.46%-9.16M | -102.93%-34.53M | -697.65%-22.41M | 90.17%-491K | 0.46%-5.25M | -62.18%-6.39M | 66.26%-17.02M | 14.65%-2.81M |
| Basic earnings per share | -1,896.01%-0.01 | -380.00%-0.024 | -28.57%-0.009 | -105.88%-0.035 | -733.33%-0.025 | 89.98%-0.0005 | 0.00%-0.005 | -75.00%-0.007 | 66.00%-0.017 | -0.003 |
| Diluted earnings per share | -1,896.01%-0.01 | -380.00%-0.024 | -28.57%-0.009 | -105.88%-0.035 | -733.33%-0.025 | 89.98%-0.0005 | 0.00%-0.005 | -75.00%-0.007 | 66.00%-0.017 | -0.003 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data